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Catheter-associated urinary tract infections (CAUTIs) occur in 290,000 US hospital patients annually, with
an estimated cost of $290 million. Two different measurement systems are being used to track the US
health care system’s performance in lowering the rate of CAUTIs. Since 2010, the Agency for Healthcare
Research and Quality (AHRQ) metric has shown a 28.2% decrease in CAUTI, whereas the Centers for
Disease Control and Prevention metric has shown a 3%-6% increase in CAUTI since 2009. Differences in
data acquisition and the definition of the denominator may explain this discrepancy. The AHRQ metric
analyzes chart-audited data and reflects both catheter use and care. The Centers for Disease Control and
Prevention metric analyzes self-reported data and primarily reflects catheter care. Because analysis of the
AHRQ metric showed a progressive change in performance over time and the scientific literature sup-
ports the importance of catheter use in the prevention of CAUTI, it is suggested that risk-adjusted
catheter-use data be incorporated into metrics that are used for determining facility performance and
for value-based purchasing initiatives.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Catheter-associated urinary tract infections (CAUTIs) are 1 of the
most common hospital acquired conditions (HACs) projected to
occur in 290,000 US hospital patients annually, costing $290
million.1 Starting in October 2014 and continuing through
September 2015, hospitals are being penalized 1% of their entire
Medicare fee schedule if their performance is ranked in the lowest
quartile for the prevention of HACs.2
The prevention of CAUTIs involves proper catheter insertion and
maintenance along with using catheters only when indicated. The
Association for Professionals in Infection Control and Epidemiology
(APIC) along with others, have reported that the most important
intervention in reducing CAUTIs is elimination or reduction in the
duration of catheter use.3-5 APIC assigned the risk factor of prolonged
catheter use (ie,>6 days) to the highest relative risk value (5.1-6.8).3
In addition, a facility’s rate of CAUTIs is a nursing-sensitive
outcome measure. High quality and adequate nurse staffing is
required for both catheter maintenance and avoidance of catheter
use.6 Centers for Disease Control and Prevention (CDC) guidelines
state that it is inappropriate to use urinary catheters “as a substitute
for nursing care of the patient or resident with incontinence.”7
Thus, avoidance of catheter use requires significant staff resources
for ambulating patients to restrooms and changing wet bed linens.
If staff resources are not allocated, then a wet environment may
occur that may foster skin breakdown.
Facilities experiencing financial stress or those that are cost-
driven may choose to cut staffing to augment a facility’s income.
Approximately 50%-70% of a hospital’s operating budget is
composed of staffing expenses, of which >50% is for nursing.6
Metrics used for hospital financial incentives are of the utmost
importance. Almost one-third of the Centers for Medicare and
Medicaid Services’ HAC reduction penalty is based on the CDC
CAUTI metric’s analysis of data submitted to the CDC National
Healthcare Safety Network (NHSN).2 This is a significant penalty,
estimated to total $373 million and levied in an all-or-none fashion
against 721 institutions.8
We evaluated 2 different CAUTI metrics, 1 from the CDC and the
other from the Agency for Healthcare Research and Quality (AHRQ),
to help determine which best represents a facility’s performance.
METHODS
Two different metrics were evaluated. The first is the CDCmetric
for NHSN data (CDC NHSN CAUTI metric). These data are self-
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reported and converted into a standardized infection ratio (SIR)
whose denominator is catheter-days divided by 1,000.9 The
numerator is the number of infections. This ratio is then multiplied
by a conversion factor that adjusts the data for various factors,
including unit type (ie, medical or surgical) unit size, and being a
major teaching facility.9,10 The baseline data were derived from
1,749 hospitals that reported data to the NHSN in 2009.9
Therewere 2 datasets available to evaluate the CDC NHSN CAUTI
metric. The first was downloaded from Data.Medicare.Gov. The
second was obtained from CDC annual reports on hospital-aquired
infections.11,12 The CDC annual reports contains a greater number of
hospitals than the Medicare.Gov data for 3 reasons13: the CDC
annual reports contain data from all reporting hospitals that report
to the NHSN, whereas the Data.Medicare.Gov data are only from
hospitals that participate in CMS Inpatient Quality Reporting pro-
gram; the closeout date to report data for the specified acquisition
dates in the CDC annual reports is a few months after the closeout
date for the data in CMS.Medicare.Gov; and the data in CMS.
Medicare.Gov are only for intensive care unit locations, whereas
the data in the CDC annual report include other locations.
The performance of the AHRQ CAUTI metric was derived from
its analysis of approximately 18,000-33,000 randomly selected
medical records per year,1 from patients with the subset of
diagnoses for myocardial infarction, heart failure, pneumonia, and
major surgical patients,14,15 from 800 randomly selected hospitals
in the Centers for Medicare andMedicaid Services Inpatient Quality
Reporting program.16 Records were reviewed using a structured
protocol1 and software tool (ie, Medicare Patient Safety Monitoring
System).1,14-17 This dataset is chart-reviewed data whose denomi-
nator is hospital discharges divided by 1,000 and whose numerator
is CAUTI Infections. The method of AHRQ sampling changed little
between the years 2010 and 2013 and the use of a consistent data
source and techniques helped to ensure that the data are unbiased.1
Because the datasets for the 2 metrics in question are derived
from different government agencies and programs, their baseline
data acquisition dates differed by 1 year.
RESULTS
CDC NHSN CAUTI metric
The SIR derived from the NHSN average hospital performance
data downloaded from Data.Medicare.Gov showed a 3% increase in
CAUTIs for the year 2013 (SIR, 1.03) compared to the 2009 baseline9
(see Table 1). These data reflect the average for hospital perfor-
mance. The annual CDC CAUTI progress reports found a 3% increase
in the 2012 SIR and a 6% increase in the 2013 SIR, compared with
the 2009 baseline.11,12
AHRQ CAUTI metric
ARHQ reported a 28.2% progressive decrease in CAUTIs between
the years 2010 and 20131,14,16 (see Table 1). If one assumes the lower
figure of reviewed medical records (n ¼ 18,000) for the sample size
and multiply this by the reported rate, the progressive improvement
in CAUTIs between the years 2010 and 2013 (reviewed records with
CAUTI / reviewed recordswithout CAUTI) has a statistical significance
of P < .011 (X2, 221/17,779; 203/17,797; 190/17,810; and 158/17,842).
DISCUSSION
Currently, the Centers for Medicare and Medicaid Services uses
the CDC NHSN CAUTI metric for its value-purchasing initiatives.
However, the validity of this initiative needs to be examined because
the AHRQ and the CDC NHSN CAUTI metric give widely varying
results. We believe that this difference results from variations in
definitions and possibly in themethod of data collection. The AHRQ
data were derived frommedical record audits and the AHRQmetric
uses a denominator of hospital discharges.1 The CDC data are self-
reported and the denominator is catheter-days.9 Which accurately
portrays our health care system’s performance?
The CDC Healthcare Infections Control Practices Advisory
Committee reported that CAUTI metrics may include the number of
CAUTIs per 1,000 catheter-days and the catheter use ratio (ie,
[urinary catheter-days / patient-days]  100).7 However, because
the CDC NHSN CAUTI metric uses a denominator of catheter-days,
efforts to minimize catheter use are negated. In addition, a finan-
cial incentive program advisor to the CDC the National Quality
Forum also uses a metric with a denominator of catheter-days.18
Because the AHRQ metric uses a denominator of hospital dis-
charges, it measures both catheter use and catheter care.
A report by Horstman et al19 suggested that using metrics with
either device-days or catheter-days were equally effective in
comparing health care-associated infections between facilities.
However, this report compared the performance for the entire
group of facilities over time and device use was not substantially
different between comparison groups. Thus, it could be argued that
the experimental design was not the best for evaluation of a metric
intended to measure device use.
Metrics that do not account for catheter use may place hospitals
that curtail their catheter use at a disadvantage. One can also make
the argument that if lower catheter use lowers infection rates, then
the catheters that are used are probably used on sicker patients.
These facilities may have a higher SIR as measured by the CDC
NHSN CAUTI metric.20 Additionally, they may also receive a finan-
cial penalty while at the same time they are increasing their
nursing staffing and providing better care.
The AHRQmetric is a nursing-sensitivemetric that promotes and
encourages high quality and adequate nurse staffing. Thus, financial
incentives based on this metric would be expected to have a far-
reaching effect on many different quality parameters throughout
the institution. It can also be argued that theCDCNHSNmetric favors
facilities thatmaybe subsidizing their operatingbudget byproviding
patient carewith lownurse staffing levels, and provide amechanism
to circumvent the intent of value-based purchasing initiatives that
are intended to promote the provision of quality health care.
Both catheter use and catheter care measurements are impor-
tant. The quantitated risk factors published by APIC3 indicate that
the catheter use component of a metric should be more heavily
weighted. Currently, not having a catheter use component in the
CDC metric appears to hinder its ability to differentiate between
good and poor performance. The AHRQ metric combines these
Table 1
Comparison of the National Healthcare Safety Network (NHSN) and Agency for
Healthcare Research and Quality (AHRQ) metrics for catheter-associated urinary
tract infections
Metric
Data and date of acquisition
2009 2010 2011 2012 2013
Centers for Disease Control and Prevention NHSN (Data.Medicare.Gov)
Standardized infection ratio9 1.00 0.99 1.03
Number of facilities w1,749 2,293 2,277
Centers for Disease Control and Prevention NHSN (HAI progress reports)
Standardized infection ratio9,11,12 1.00 1.03 1.06
Number of facilities w1,749 3,597 2,781
AHRQ1,14,16
Infections/1,000 discharges 12.25 11.30 10.58 8.8*
Baseline ratio 1.00 0.92 0.86 0.72*
Number of charts1 w18,000-33,000 medical records from 800
hospitals
*Preliminary Data.
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components (ie, use and care) and by demonstrating a progressive
significant improvement, appears to differentiate good versus poor
performance on a systemwide level.
Concerns regarding the reliability of self-reported data has been
an issue with patient advocates and was heightened by the March
2010 US Department of Health and Human Services Office of
Inspector General report (OEI-06-08-00,221),21 which found that
audited hospitals did not have incident reports for 93% of adverse
events. The CDC reports that only 20 of the 50 states check CDC
NHSN CAUTI data for quality and completeness.11 To have the most
accurate value-based purchasing initiatives, the health care in-
dustry should be supportive of expanded data verification.
LIMITATIONS
Although the AHRQ metric appears to be valid in describing
performance on a systemwide level, it is not risk-adjusted, and
therefore may not have the same validity with comparisons be-
tween facilities. This study is not intended to suggest a final metric
for CAUTI measurement, but to act as an impetus for the develop-
ment of a risk-adjusted AHRQ metric.
The AHRQ and the CDCNHSNdatasets were collected differently.
The AHRQ data were not derived from claims data but from a
structuredmedical record review.TheCDCNHSNdatawere collected
by hospital employees with an infectious disease background and
not independently verified. There are concerns regarding the
integrity of nonindependently verified facility data that are collected
by personnel having a conflict of interest with the facility.
The datasets used to compare the 2 metrics were derived from
very large but different patient populations. Although there is
significant overlap in these populations, the derived rates for any
1 year are not comparable between the two data sets without the
implementation of a conversion factor as described by AHRQ.1
However, our study analyzes the change in the incidence of CAU-
TIs across time and for such large and overlapping patient pop-
ulations this change should be comparable between the 2 datasets.
At the very least, the observed different results given by the 2
metrics, along with the data fromAPIC and other authors,3-5 dictate
a reevaluation of the use of the current CDC NHSN metric in value-
based purchasing initiatives.
CONCLUSIONS
Regardless of which factors are responsible for the widely
varying results in these 2 government CAUTI metrics, the fact that
the results are so different raises questions regarding the accuracy
of the rates for CAUTIs that are currently used in value-based pur-
chasing initiatives. In its present form, we question whether the
CDC NHSN CAUTI metric can adequately differentiate between
well-performing and poorly performing facilities. The Centers for
Medicare and Medicaid Services may need to redefine the metric
used for the CAUTI portion of their HAC reduction program by using
a denominator for risk-adjusted hospital discharges or by incor-
porating a risk-adjusted catheter use ratio. In addition, data veri-
fication should be considered a high priority when financial
incentives are being levied.
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